Description

NSE announces face value split for Anlon Healthcare Limited (AHCL) from Rs. 10 to Rs. 2 per equity share, effective April 24, 2026.

Summary

NSE’s Listing Department has issued a circular (Ref No: 0629/2026) informing members that Anlon Healthcare Limited (Symbol: AHCL) will undergo a face value split. The paid-up value of its equity shares will change from Rs. 10 to Rs. 2 per share, effective April 24, 2026.

Key Points

  • Anlon Healthcare Limited (AHCL) is undergoing a face value split
  • Existing face value and paid-up value: Rs. 10 per share
  • New face value and paid-up value: Rs. 2 per share
  • Split ratio effectively 5:1 (Rs. 10 → Rs. 2)
  • Circular issued by NSE Listing Department under Ref No: NSE/CML/73754
  • Signed by Dhwani Shah, Manager, NSE

Regulatory Changes

The face value and paid-up value of equity shares of Anlon Healthcare Limited will be revised as per the approved corporate action. All trading and settlement parameters on NSE will be updated to reflect the new face value of Rs. 2 per share from the effective date.

Compliance Requirements

  • All NSE members are informed to take note of the change in face value
  • Members must update their systems and records to reflect the new face value of Rs. 2 for AHCL shares effective April 24, 2026
  • Market participants holding AHCL shares should account for the proportional increase in share quantity post-split

Important Dates

  • Circular Date: April 15, 2026
  • Effective Date: April 24, 2026 (face value change takes effect)

Impact Assessment

The face value split of AHCL from Rs. 10 to Rs. 2 represents a 5:1 split ratio. Post-split, shareholders will hold five shares for every one share currently held, with the per-share price adjusting proportionally. This typically improves liquidity and makes the stock more accessible to retail investors. No negative financial impact is expected; total market capitalization remains unchanged. Trading members and depository participants should update their records accordingly before the effective date of April 24, 2026.

Impact Justification

Stock split affects existing shareholders and trading parameters for AHCL, but is a routine corporate action with no negative implications. Impact is medium as it changes per-share face value and affects price discovery post-split.